Rhonda Farnum, SVP of communications and medical affairs at Theravance Biopharma ($TBPH), sold shares eight times on the open market over the past year for a total of nearly $1 million. Her most recent sale occurred on December 3, 2025. These transactions rank 4,941st among 11,678 insiders, trailing the average sale value of $8.6 million across about 6.4 trades per seller. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | A | Ordinary Shares | 18750 | $0.00 | 251,449.0000 | 51,507,000 | 8.06% | 0.04% |
| March 16, 2026 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 7766 | $13.92 | 232,699.0000 | 51,908,000 | 3.23% | 0.01% |
| March 16, 2026 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 15534 | $14.00 | 240,465.0000 | 51,908,000 | 6.07% | 0.03% |
| March 16, 2026 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 7767 | $13.92 | 255,999.0000 | 51,908,000 | 2.94% | 0.01% |
| Feb. 20, 2026 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 13929 | $19.66 | 263,766.0000 | 51,908,000 | 5.02% | 0.03% |
| Dec. 3, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 15534 | $18.75 | 277,695.0000 | 51,908,000 | 5.30% | 0.03% |
| Dec. 3, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 7766 | $18.75 | 293,229.0000 | 51,908,000 | 2.58% | 0.01% |
| Dec. 3, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 7767 | $18.75 | 300,995.0000 | 51,908,000 | 2.52% | 0.01% |
| Nov. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9060 | $17.90 | 308,762.0000 | 51,908,000 | 2.85% | 0.02% |
| Aug. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9096 | $13.39 | 317,822.0000 | 50,726,000 | 2.78% | 0.02% |
| July 14, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 682 | $11.39 | 336,236.0000 | 50,726,000 | 0.20% | 0.00% |
| July 14, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 5318 | $11.39 | 330,918.0000 | 50,726,000 | 1.58% | 0.01% |
| July 14, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 4000 | $11.39 | 326,918.0000 | 50,726,000 | 1.21% | 0.01% |
| June 2, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 24000 | $11.00 | 336,918.0000 | 49,706,000 | 6.65% | 0.05% |
| May 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9120 | $9.45 | 360,918.0000 | 49,706,000 | 2.46% | 0.02% |
| April 21, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 4000 | $9.00 | 370,038.0000 | 49,706,000 | 1.07% | 0.01% |
| Feb. 28, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | A | Ordinary Shares | 75000 | $0.00 | 374,038.0000 | 48,847,000 | 25.08% | 0.15% |
| Feb. 10, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | A | Ordinary Shares | 5283 | $0.00 | 314,848.0000 | 48,847,000 | 1.71% | 0.01% |
| Feb. 20, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 15810 | $9.66 | 299,038.0000 | 48,847,000 | 5.02% | 0.03% |
| Jan. 21, 2025 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 4000 | $9.00 | 309,565.0000 | 48,847,000 | 1.28% | 0.01% |
| Nov. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9178 | $9.97 | 313,565.0000 | 49,038,000 | 2.84% | 0.02% |
| Nov. 11, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 4000 | $9.00 | 322,743.0000 | 49,038,000 | 1.22% | 0.01% |
| Aug. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9222 | $8.22 | 326,743.0000 | 48,747,000 | 2.74% | 0.02% |
| July 10, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 4000 | $9.00 | 335,965.0000 | 48,747,000 | 1.18% | 0.01% |
| May 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 9268 | $9.10 | 339,965.0000 | 48,283,000 | 2.65% | 0.02% |
| April 2, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | A | Ordinary Shares | 37500 | $0.00 | 349,233.0000 | 48,283,000 | 12.03% | 0.08% |
| Feb. 22, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | S | Ordinary Shares | 1254 | $8.71 | 311,733.0000 | 55,303,000 | 0.40% | 0.00% |
| Feb. 20, 2024 | Theravance Biopharma, Inc. | $TBPH | Farnum Rhonda | SVP, COMM & MEDICAL AFFAIRS | F | Ordinary Shares | 18219 | $8.92 | 312,987.0000 | 55,303,000 | 5.50% | 0.03% |